News & Updates
Filter by Specialty:
Testosterone therapy in women may lower risks of MACE, breast cancer
Women on testosterone therapy (TTh) show a lower risk of major adverse cardiac events (MACE) than matched controls, while postmenopausal women have a comparable MACE risk and a similar or significantly reduced risk of breast cancer on age-based subanalysis, reports a study.
Testosterone therapy in women may lower risks of MACE, breast cancer
04 Jun 2024
Machine learning–based model predicts 1-year risk of severe hypoglycaemia in older DM patients
Researchers from the Chinese University of Hong Kong (CUHK) have developed a novel machine learning–based model for predicting 1-year risk of severe hypoglycaemia in older patients with diabetes mellitus (DM).
Machine learning–based model predicts 1-year risk of severe hypoglycaemia in older DM patients
01 Jun 2024
Orthostatic hypotension ups dementia risk in T2DM
Having an orthostatic hypotension (OH) appears to promote the development of dementia in type 2 diabetes mellitus (T2DM) patients with mild cognitive impairment (MCI), suggests a study.
Orthostatic hypotension ups dementia risk in T2DM
31 May 2024
Metformin plus liraglutide eases glycemia but not gluconeogenesis in youth-onset T2D
Use of metformin with or without liraglutide results in improved glycaemia but falls short of suppressing the high rates of gluconeogenesis in patients with youth-onset type 2 diabetes (Y-T2D), reports a study.
Metformin plus liraglutide eases glycemia but not gluconeogenesis in youth-onset T2D
28 May 2024
Impaired thyroid hormone sensitivity ups MACE risk in angiography patients
Euthyroid patients undergoing coronary angiography who have impaired sensitivity to thyroid hormone are at increased risks of major adverse cardiovascular events (MACE) and cardiovascular death, a recent study has shown.
